Randall Duckert
Radiation Oncology · Hastings, NENPI 1376508960
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $272 and has fallen 71.6% since, to $77 in 2024.
Across 44 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$167
- Seagen Inc.$71
- Varian Medical Systems, Inc.$61
- Medtronic$55
- Novartis$51
- Daiichi Sankyo Inc.$40
- plus $313 from 19 others
What the payments were for
- Food & beverage$757100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $167 |
| Seagen Inc. | 4 | $71 |
| Varian Medical Systems, Inc. | 1 | $61 |
| Medtronic | 3 | $55 |
| Novartis | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Pfizer | 2 | $34 |
| Incyte Corporation | 2 | $27 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| Pharmaessentia USA Corporation | 1 | $19 |
| Novocure Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| CTI Biopharma Corp. | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Sanofi | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Coherus Oncology, Inc. | 1 | $12 |
| Ipsen Biopharmaceuticals, Inc | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$757 in reported general payments places this provider in the 60th percentile of 32 radiation oncology providers in Nebraska.
Other radiation oncology in Hastings
- Alireza MirmiranOmaha$13K
- Joseph Kam ChiuLincoln$12K
- Jacqueline KellyLincoln$5K
- Michael BaineOmaha$4K
- Mark StavasLincoln$4K
- Hadi ZahraNorfolk$3K
- Phillip HynesLincoln$2K
- Todd HlavatyNorth Platte$2K
- Max ChiuOmaha$2K
- Kevin YieeLincoln$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.